Literature DB >> 9729418

Expression of iron transport proteins and excessive iron accumulation in the brain in neurodegenerative disorders.

Z M Qian1, Q Wang.   

Abstract

New findings on the role of LfR (lactotransferrin receptor), MTf (melanotransferrin), CP (ceruloplasmin) and DCT1 (Divalent Cation Transporter) in brain iron transport, obtained during the past 3 years, are important advances in the fields of physiology and pathophysiology of brain iron metabolism. According to these findings, disruption in the expression of these proteins in the brain is probably one of the important causes of the altered brain iron metabolism in age-related neurodegenerative diseases, including Parkinson's Disease, Alzheimer's disease, Huntington's disease and amyotrophic lateral sclerosis. Further studies on the involvement of LfR, MTf and DCT1 in iron uptake by and CP in iron egress from different types of brain cells as well as control mechanisms of expression of these proteins in the brain are critical for elucidating the causes of excessive accumulation of iron in the brain and neuronal death in neurodegenerative diseases. Copyright 1998 Elsevier Science B.V.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9729418     DOI: 10.1016/s0165-0173(98)00012-5

Source DB:  PubMed          Journal:  Brain Res Brain Res Rev


  56 in total

Review 1.  The role of iron in neurodegeneration: prospects for pharmacotherapy of Parkinson's disease.

Authors:  K A Jellinger
Journal:  Drugs Aging       Date:  1999-02       Impact factor: 3.923

2.  Morphological changes of myelin sheaths in rats intracranially injected with apotransferrin.

Authors:  Cecilia B Marta; Pablo Paez; Margarita Lopez; Amanda Pellegrino de Iraldi; Eduardo F Soto; Juana M Pasquini
Journal:  Neurochem Res       Date:  2003-01       Impact factor: 3.996

3.  Deferiprone reduces amyloid-β and tau phosphorylation levels but not reactive oxygen species generation in hippocampus of rabbits fed a cholesterol-enriched diet.

Authors:  Jaya R P Prasanthi; Matthew Schrag; Bhanu Dasari; Gurdeep Marwarha; April Dickson; Wolff M Kirsch; Othman Ghribi
Journal:  J Alzheimers Dis       Date:  2012       Impact factor: 4.472

4.  Complex relationships between cerebral blood flow and brain atrophy in early Huntington's disease.

Authors:  J Jean Chen; David H Salat; H Diana Rosas
Journal:  Neuroimage       Date:  2011-09-16       Impact factor: 6.556

5.  Angiotensin II inhibits iron uptake and release in cultured neurons.

Authors:  Yong Liu; Suna Huang; Fang Du; Guang Yang; Li Rong Jiang; Chao Zhang; Zhong-ming Qian
Journal:  Neurochem Res       Date:  2014-03-30       Impact factor: 3.996

6.  Neuroprotection by 7-nitroindazole against iron-induced hippocampal neurotoxicity.

Authors:  M Omer Bostanci; Faruk Bağirici
Journal:  Cell Mol Neurobiol       Date:  2007-10-27       Impact factor: 5.046

7.  Distribution of ferritin in the rat hippocampus after kainate-induced neuronal injury.

Authors:  En Huang; Wei-Yi Ong
Journal:  Exp Brain Res       Date:  2004-11-20       Impact factor: 1.972

8.  Expression of Iron Transporters and Pathological Hallmarks of Parkinson's and Alzheimer's Diseases in the Brain of Young, Adult, and Aged Rats.

Authors:  Li-Na Lu; Zhong-Ming Qian; Ka-Chun Wu; Wing-Ho Yung; Ya Ke
Journal:  Mol Neurobiol       Date:  2016-08-30       Impact factor: 5.590

9.  Lipopolysaccharide induces a significant increase in expression of iron regulatory hormone hepcidin in the cortex and substantia nigra in rat brain.

Authors:  Qin Wang; Fang Du; Zhong-Ming Qian; Xiao Hu Ge; Li Zhu; Wing Ho Yung; Lei Yang; Ya Ke
Journal:  Endocrinology       Date:  2008-05-01       Impact factor: 4.736

10.  Genistein protects primary cortical neurons from iron-induced lipid peroxidation.

Authors:  Kwok Ping Ho; Lin Li; Li Zhao; Zhong Ming Qian
Journal:  Mol Cell Biochem       Date:  2003-05       Impact factor: 3.396

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.